The RAPS store will be under maintenance Saturday, 17 April between 5 AM and 12 PM EST. Store functionality may be unavailable at times during this window.
We apologize for any inconvenience caused during this time.

Regulatory Focus™ > News Articles > Perspective: FDA’s Draft Good Reprint Practices

Perspective: FDA’s Draft Good Reprint Practices

Posted 01 May 2008

In February 2008, FDA published the draft guidance, Good Reprint Practices for the Distribution of Medical Journal Articles and Medical or Scientific Reference Publications on Unapproved New Uses of Approved Drugs and Approved or Cleared Medical Devices. The draft was issued for comment and is intended to provide insight into what conditions make the dissemination of off-label information nonpromotional and acceptable in the agency's view.1

 

© 2021 Regulatory Affairs Professionals Society.

Regulatory Focus newsletters

All the biggest regulatory news and happenings.

Subscribe